Growth hormone secretagogue therapy to support muscle, fat loss, and physical performance — prescribed by Australian doctors, without anabolic steroids.
Growth hormone secretagogues (GHS) work by stimulating your pituitary gland to produce and release more of your own growth hormone — in a pulsatile, physiological pattern that mirrors natural GH secretion. This is fundamentally different from exogenous GH injections, which override the body's own regulatory system.
Elevated GH supports increased muscle protein synthesis, enhanced fat oxidation, improved recovery from training, and better sleep quality. These effects compound over 3–6 months of consistent use, particularly when combined with appropriate resistance training and nutrition.
The CJC-1295 + Ipamorelin combination is the most commonly prescribed GH secretagogue protocol. CJC-1295 is a GHRH (Growth Hormone Releasing Hormone) analogue with a prolonged half-life, providing a sustained baseline elevation in GH secretion. Ipamorelin is a selective ghrelin receptor agonist that triggers a strong, pulsatile GH release without stimulating cortisol or prolactin — making it highly selective and well-tolerated.
Together, they produce a synergistic GH pulse that significantly exceeds what either peptide achieves alone, while maintaining a physiological release pattern.
Ipamorelin used as a standalone peptide is a good option for patients new to GH secretagogues or those seeking a more conservative starting point. Its selectivity for GH release (without cortisol or prolactin stimulation) makes it among the best-tolerated options in this class.
Prescription and dispatch. Improved sleep quality and recovery is often the first reported effect — GH is primarily released during deep sleep.
Subtle improvements in body composition begin to emerge. Training recovery improves noticeably. Some patients report improved skin quality and mood.
Meaningful muscle and fat composition changes for most patients. These compound with continued training stimulus and appropriate nutrition.
Maximum body composition benefit typically seen in this window. Follow-up consultations ensure the program remains clinically appropriate.
Check your eligibility and book your consultation with a Natura doctor today.
CJC-1295 and Ipamorelin are unregistered medicines in Australia, prescribed under TGA prescribing authority by AHPRA-registered doctors and compounded by TGO 101-compliant pharmacists. These peptides are prohibited substances under the WADA Code — not appropriate for athletes in tested sport without a TUE. Individual results may vary. Not suitable for patients under 18.